Simulcast on YouTube, Facebook & Twitter | Thursday, August 20, 2026 @ 8:00 PM EDT (GMT-4)
Veteran UFO researcher, scientist and author Jacques Vallée joins Martin Willis for an extraordinary conversation about his newest book, Forbidden Science 7: Final Report—The Journals of Jacques Vallée 2020–2025. The seventh and final volume of Vallée’s remarkable journals chronicles a pivotal five-year period in the history of the UFO phenomenon—one marked by government hearings, whistleblower allegations, growing public discussion of UAP and renewed demands for disclosure. But after more than six decades of investigation, Vallée continues to caution that the phenomenon may be far stranger and more consequential than the conventional idea of extraterrestrial spacecraft visiting Earth. In this conversation, Jacques discusses what he witnessed behind the scenes during the rapidly changing years from 2020 through 2025, what the public still misunderstands about UFO disclosure and why revelations surrounding the phenomenon may carry profound scientific, cultural and spiritual implications. We also explore the patterns that have shaped Vallée’s work: physical evidence, close encounters, consciousness, secrecy, deception, folklore and the possibility that the phenomenon has influenced humanity throughout history. Is society prepared for what may be revealed? What have governments learned and what remains genuinely unknown? After a lifetime spent pursuing forbidden science, how does Jacques Vallée now interpret the mystery?
Official WEBSITE
BIO: Jacques F. Vallée is a principal at Documatica Financial and a diversified investor with a passion for technology startups in space development, medical equipment and information management. He earned a Bachelors Degree in mathematics from the Sorbonne, a Masters Degree in astrophysics from Lille University and a PhD in Computer Science /AI from Northwestern University (1967).
Based in Silicon Valley, Jacques has served as a founder and general partner in five venture funds, including NASA’s “Red Planet Capital”. Among the companies for which he spearheaded early-stage financings, fourteen achieved IPOs, notably Electronics for Imaging, Accuray Systems (developers of the “Cyberknife” for cancer surgery), NeoPhotonics (Nanotechnology for optical networks), Mercury Interactive, P-Com, Isocor, Regeneration Technologies, Harmonic Lightwaves, Ixys, Integrated Packaging, E.Piphany, Sangstat Medical, Com21 and Synaptic Pharmaceuticals, specialized in neurotransmitter biology. He served as a member of the Board of Directors of many of these firms.
Other companies financed by Jacques (in particular, HandyLab that produced an instrument recognized as “transformative for oncology”) were successfully acquired by Becton-Dickinson, Intel, Lucent, AOL, Cisco, Wilson Greatbatch and Intuitive Surgical.
In his early career Jacques worked at Paris Observatory and at the astronomy department of the University of Texas in Austin, where he co-developed the first computer-based map of planet Mars. Moving to California after management positions with Shell and RCA, he implemented (with Jake Feinler) the first Network Information Center on the Arpanet and later served as a principal investigator for DARPA and NSF. Jacques has published several textbooks about computer networking and has maintained a long-term interest in unidentified flying objects, currently (2020) serving on the expert committee of the French CNES tasked with studying such reports. He received the Jules Verne Prize for his first science-fiction novel (in French). He resides between San Francisco and Paris. He has two children and three grandchildren.
Mail may be addressed to Jacques Vallée P.O. Box 641650 San Francisco, CA 94164